Literature DB >> 9351403

Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process.

V Dubernard1, B B Arbeille, M B Lemesle, C Legrand.   

Abstract

In a previous study, we have demonstrated that the platelet adhesive glycoprotein thrombospondin-1 (TSP-1) interacts specifically with the cytoskeletal protein alpha-actinin in a solid-phase binding assay. Stored in the alpha-granules of platelets, TSP-1 is secreted during cell activation and binds to the plasma membrane promoting the platelet macroaggregate formation. However, the molecular mechanism by which TSP-1 reaches and binds to the platelet surface is to date unelucidated. alpha-Actinin is an actin-binding and actinin-cross-linking protein that is present in most cells and may act as a link between the bundles of F-actin and the plasma membrane. In this study, we have investigated a possible interaction of alpha-actinin with TSP-1 in platelets by examining their respective subcellular location during the platelet activation process. By indirect immunofluorescence. alpha-actinin was found to display a granular staining in resting platelets similar to that of TSP-1. Performing postembedding immunogold labeling for electron microscopy, we detected the presence of alpha-actinin throughout the cytoplasm, but the strongest gold staining was found in organelles identified as alpha-granules on the basis of their ultrastructure and TSP-1 content. With the use of double immunogold labeling on platelets at different stages of activation by thrombin, both alpha-actinin and TSP-1 were seen redistributing from the alpha-granules to the platelet surface via the open canalicular system (OCS). At the same time, the cytoplasmic alpha-actinin concentrated toward the plasma membrane, but no colocalization with the F-actin bundles was evidenced. Finally, preembedding immunogold labeling and immunoprecipitation of 125I-surface-labeled, thrombin-activated platelets further demonstrated that alpha-actinin was expressed on the plasma membrane in the absence of any detectable expression of actin and that it could from molecular complexes with TSP-1 on activated platelets. These results suggest that alpha-actinin found to be present on the platelet surface together with TSP-1 originates in the alpha-granules by fusion of the alpha-granules with the plasma membrane during platelet exocytosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351403     DOI: 10.1161/01.atv.17.10.2293

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

1.  A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration.

Authors:  Peter Schubert; Jonathan N Thon; Geraldine M Walsh; Cindy H I Chen; Edwin D Moore; Dana V Devine; Juergen Kast
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

2.  Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Authors:  Arnaud Bonnefoy; Kim Daenens; Hendrik B Feys; Rita De Vos; Petra Vandervoort; Jos Vermylen; Jack Lawler; Marc F Hoylaerts
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

Review 3.  Platelet effects on ovarian cancer.

Authors:  Ashley N Davis; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Semin Oncol       Date:  2014-04-23       Impact factor: 4.929

Review 4.  Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

Authors:  Natasha M Rogers; Mingyi Yao; Enrico M Novelli; Angus W Thomson; David D Roberts; Jeffrey S Isenberg
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

5.  Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.

Authors:  Junko Haraga; Keiichiro Nakamura; Chiaki Omichi; Takeshi Nishida; Tomoko Haruma; Tomoyuki Kusumoto; Noriko Seki; Hisashi Masuyama; Norihisa Katayama; Susumu Kanazawa; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2016-09-21

6.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.

Authors:  Jeffrey I Zwicker; Flora Peyvandi; Roberta Palla; Rossana Lombardi; Maria Teresa Canciani; Andrea Cairo; Diego Ardissino; Luisa Bernardinelli; Kenneth A Bauer; Jack Lawler; Pier Mannucci
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

7.  Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice.

Authors:  Prem Prakash; Paresh P Kulkarni; Anil K Chauhan
Journal:  Blood       Date:  2014-10-24       Impact factor: 22.113

8.  Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.

Authors:  C E Holmes; J E Levis; D L Ornstein
Journal:  Clin Exp Metastasis       Date:  2009-05-15       Impact factor: 5.150

9.  Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a.

Authors:  Maria Pia Rastaldi; Silvia Armelloni; Silvia Berra; Min Li; Marzia Pesaresi; Helga Poczewski; Brigitte Langer; Dontscho Kerjaschki; Anna Henger; Simone Monika Blattner; Matthias Kretzler; Rudiger Wanke; Giuseppe D'Amico
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Proteomics strategy for identifying candidate bioactive proteins in complex mixtures: application to the platelet releasate.

Authors:  Roisin O'Connor; Lorna M Cryan; Kieran Wynne; Andreas de Stefani; Desmond Fitzgerald; Colm O'Brien; Gerard Cagney
Journal:  J Biomed Biotechnol       Date:  2010-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.